eIF1AY Antibodies

Santa Cruz Biotechnology delivers a wide array of eIF1AY monoclonal antibodies for research focused on understanding eIF1AY's role in cellular processes. The monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). eIF1AY, or eukaryotic translation initiation factor 1A, Y isoform, plays a critical role in the initiation of protein synthesis by facilitating the assembly of the translation initiation complex. eIF1AY is essential for the regulation of gene expression and has been implicated in various cellular processes, including cell growth and differentiation. Understanding eIF1AY function is vital for elucidating its involvement in diseases such as cancer and other disorders related to protein synthesis. Researchers can explore translation initiation mechanisms through multiple experimental approaches using specific conjugates including horseradish peroxidase (HRP), phycoerythrin (PE), and fluorescein isothiocyanate (FITC). Advanced research techniques enable detailed investigation of eIF1AY's cellular distribution and molecular interactions. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of eIF1AY's role in health and disease.